<!DOCTYPE html>
<html lang="en" xmlns:ng="http://angularjs.org" id="ng-app" ng-app="myweb">
<head>
  <meta http-equiv="X-UA-Compatible" content="IE=Edge">
  <meta charset="utf-8">
  <title>Benefits of Naftin | Naftin.com</title>
  <meta name="description" content="">
  <meta name="keywords" content="">
  <meta id="viewport" name="viewport" content="width=device-width, maximum-scale=1">
  <base href="/" target="_self">
  <link href="//cloud.typenetwork.com/projects/825/fontface.css/" rel="stylesheet" type="text/css">
  <script type="text/javascript" src="//fast.fonts.net/jsapi/0ec7f1a2-9bb2-481f-9711-157a689640c7.js"></script>
  <script src="//ajax.googleapis.com/ajax/libs/webfont/1.5.18/webfont.js"></script>
  <script>
    WebFont.load({
      google: {
        families: ['Open Sans:300,400,600,700']
      }
    });
  </script>
  <script src="js/vendor.js"></script>
  <script src="js/templates.js"></script>
  <script src="js/app.js"></script>
  <script src="js/isi-scroll.js"></script>
  <script src="js/index.js"></script>
  <link rel="shortcut icon" href="assets/favicon.png">
  <meta http-equiv="Cache-Control" content="no-cache, no-store, must-revalidate">
  <meta http-equiv="Pragma" content="no-cache">
  <meta http-equiv="Expires" content="0">
  <meta name="format-detection" content="telephone=no">
  <link rel="stylesheet" href="css/styles.css"/>
</head>
<body>
  <div ng-controller="MainController">
    <div class="container">
      <div id="page-wrapper">
        <div class="page-masthead">
          <div class="header">
            <div class="logo"><a class="img" href="/hcp-index.html" target="_self"></a>
            </div>
            <div class="nav-toggle" ng-class="navToggle ? 'nav-show' : 'nav-hide'"><a href ng-click="navToggle = !navToggle"></a></div>
          </div>
          <div class="nav nav-hide" ng-class="navToggle ? 'nav-show' : 'nav-hide'">
            <ul class="hcp-nav">
              <li class="hcp-nav__item active"><a href="hcp-benefits-of-naftin.html" target="_self">Benefits of NAFTIN 2%</a>
                <ul class="sub-nav">
                  <li class="sub-nav__item active"><a href="hcp-gel-advantage.html" target="_self">The Gel Advantage</a></li>
                  <li class="divider"></li>
                </ul>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-efficacy.html" target="_self">Efficacy</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-how-naftin-works.html" target="_self">Reservoir Effect</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-co-pay-assistance.html" target="_self">Co-Pay Assistance</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="/assets/Sample_Request_Form_Naftin_FILLABLE.pdf" target="_blank">Sample Request Form</a>
              </li>
            </ul>
            <ul class="hcp-header-nav">
              <li class="hcp-header-nav__item "><a href="index.html" target="_self">For Patients</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a href="/assets/naftingel_pi.pdf" target="_blank">Full Prescribing Information</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a scroll-to-item scroll-to="#page-isi">Important Safety Information</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a href="hcp-contact-us.html" target="_self">Contact Us</a>
              </li>
            </ul>
          </div>
        </div>
        <div class="page-header">
          <div class="naftin-gel"></div>
        </div>
        <div class="page-content hcp-benefits-of-naftin">
          <div class="copy-widish">
            <p class="eyebrow">Summary of benefits</p>
            <h1>NAFTIN<sup>®</sup> <span class="regular_caps">(Naftifine HCl) </span>Gel, 2%: An antifungal that successfully treats the most common dermatophyte infections<sup>3,9,10</sup></h1>
            <div id="callouts">
              <div class="trichophyton-rubrum">
                <div class="graphic">
                  <div class="img"></div>
                </div>
                <div class="content"><strong><em>Trichophyton rubrum</em></strong></div>
              </div>
              <div class="trichophyton-mentagrophytes">
                <div class="graphic">
                  <div class="img"></div>
                </div>
                <div class="content"><strong><em>Trichophyton mentagrophytes</em></strong></div>
              </div>
              <div class="epidermophyton-floccosum">
                <div class="graphic">
                  <div class="img"></div>
                </div>
                <div class="content"><strong><em>Epidermophyton floccosum</em></strong></div>
              </div>
            </div>
            <div class="callout">
              <h2>Let your patients experience all the benefits of NAFTIN<sup>®</sup> Gel, 2%</h2>
              <ul>
                <li>Proven antifungal efficacy with once-daily, 2-week dosing<sup>3</sup></li>
                <li>A fungicidal allylamine that attacks offending microorganisms<sup>3</sup></li>
                <li>Highest efficacy observed at 6  weeks (4 weeks post last treatment) with NAFTIN<sup>®</sup> Gel, 2%<sup>3</sup></li>
                <li>Adverse events comparable to vehicle<sup>3</sup>
                  <ul>
                    <li>Application site reactions were the most common adverse reactions seen in clinical trials with NAFTIN<sup>®</sup> Gel, 2%<sup>3</sup></li>
                  </ul>
                </li>
                <li>Aqueous-based gel, which has excellent penetration properties and is rapid drying<sup>1,3</sup></li>
              </ul><a class="button" href="hcp-gel-advantage.html" target="_self">Learn more</a>
            </div>
          </div>
        </div>
        <div id="page-isi-scroll-trigger"></div>
        <div class="fixed" id="page-isi">
          <div class="isitrigger"><span class="desktop expand show">Expand</span><span class="desktop collapse">Collapse</span><span class="mobile expand show">Click to See Complete Safety Information</span><span class="mobile collapse">Close</span></div>
          <div class="overflow">
            <div class="gel hcp-isi">
              <h3>NAFTIN<sup>&reg;</sup> (Naftifine HCl) Gel, 2%</h3>
              <div class="col-1 isi-text">
                <h4>INDICATIONS AND USAGE:</h4>
                <p>NAFTIN Gel, 2% is an allylamine antifungal indicated for the treatment of interdigital tinea pedis caused by the organisms <em>Trichophyton rubrum</em>,<em> Trichophyton mentagrophytes</em>, and <em>Epidermophyton floccosum</em> in patients 12 years of age and older.</p>
                <h4 style="font-family: 'Aechen W01 Medium';">IMPORTANT SAFETY INFORMATION</h4>
                <h4 style="font-family: 'Aechen W01 Medium';">ADVERSE REACTIONS:</h4> 
                <p>In clinical trials with NAFTIN Gel, 2%, the most common adverse reactions (2%) were application site reactions.</p>
              </div>
              <div class="col-2 isi-text">
                <h4>WARNINGS AND PRECAUTIONS:</h4>
                <p>If redness or irritation develops with the use of NAFTIN Gel, 2%, <span class="warning">treatment should be discontinued</span>.</p>
                <p class="maroon"><b>Please click <a href="/assets/naftingel_pi.pdf" target="_blank" style="font-weight: 600;">here</a> for full Prescribing Information about NAFTIN Gel, 2%.</b></p>
              </div>
            </div>
            <div class="references"> 
              <p class="footnote">
               <strong>REFERENCES: 1.</strong> Vlahovic TC. Choosing the right vehicle. <i>Podiatry Management.</i> 
               June/July 2008;209-218. 
               <strong>2.</strong> Data on file, Sebela Pharmaceuticals Inc. 
               <strong>3.</strong> NAFTIN (naftifine hydrochloride) Gel 2% [package insert]. Roswell, GA; Sebela Pharmaceuticals Inc.; December 2017. 
               <strong>4.</strong> Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 
               US Food and Drug Administration/Center for Drug Evaluation and Research website. 
               https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=204286&Appl_type=N. Accessed November 7, 2017. 
               <strong>5.</strong> Plaum S, Verma A, Fleischer AB, Olayinka B, Hardas B. Detection and relevance 
               of naftifine hydrochloride in the stratum corneum up to four weeks following the last application 
               of naftifine cream or gel 2%. <i>J Drugs Dermatol</i>. 2013;12(9):1004-1008. 
               <strong>6.</strong> Stein Gold L, Parish L, Vlahovic T, Kircik L, et al. Efficacy and safety of 
               naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled 
               results from two multicenter, randomized, double-blind, vehicle-controlled trials. 
               <i>J Drugs Dermatol</i>. 2013;12(8):911-918. 
               <strong>7.</strong> Brennan B, Leyden JJ. Overview of topical therapy for common superficial 
               fungal infections and the role of new topical agents. <i>J Am Acad Dermatol</i>. 1997;36:S3-S8. 
               <strong>8.</strong> NAFTIN 2% Co-Pay Savings Offer. Sebela Pharmaceuticals Inc., January 2017. 
               <strong>9.</strong> Parish LC, Parish JL, Routh HB, et al. A randomized, double-blind, 
               vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. 
               <i>J Drugs Dermatol</i>. November 2011;10(11):1282-1288.  
               <strong>10.</strong> Parish LC, Parish JL, Routh HB, et al. A double-blind, randomized, 
               vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. 
               <i>J Drugs Dermatol</i>. October 2011;10(10):1142-1147. 
               <strong>11.</strong> Robbins CM, Elston DM. Tinea pedis treatment & management. Medscape Web site. 
               http://emedicine.medscape.com/article/1091684-overview. Updated November 19, 2015. Accessed 
               February 22, 2016.
               <strong>12.</strong> Phillips, RM, Rosen T. Topical antifungal agents. Allylamines and 
               benzylamines. In: Wolverton, SE, ed. <i>Comprehensive Dermatologic Drug Therapy</i>. 3rd ed. 
               Elsevier Inc. Ebook; 2013:460-472.<br><br>
             </p>
           </div>
         </div>
       </div>
       <div id="page-footer">
        <div class="footer-nav-wrapper">
          <ul class="hcp-footer-nav">
            <li class="hcp-footer-nav__item "><a href="http://sebelapharma.com" target="_blank">About Us</a>
            </li>
            <li class="divider"></li>
            <li class="hcp-footer-nav__item "><a target="_blank" href="http://www.sebelapharma.com/privacy-usage-policy/" target="_self">Privacy &amp; Usage Policy</a>
            </li>
            <li class="divider"></li>
            <li class="hcp-footer-nav__item "><a href="hcp-contact-us.html" target="_self">Contact Us</a>
            </li>
            <li class="divider"></li>
            <li class="patient-footer-nav__item "><a href="http://sebelapharma.com" target="_blank">SebelaPharma.com</a>
            </li>
          </ul>
        </div>
        <div class="footer">
          <p class="small">NAFTIN Gel, 2% is manufactured for Sebela Pharmaceuticals Inc., Roswell, GA 30076.</p>
          <p class="small">
           NAFTIN and the NAFTIN logo are registered trademarks of Sebela International Ltd.<br>
           Fungicidal Power You Can Trust is a registered trademark of Sebela International Ltd.<br/>
           &copy;2019 Sebela Pharmaceuticals Inc. All rights reserved. 
           <span class="nowrap">NAF-772-0119E</span>
         </p>
         <p class="small">This site is intended for US residents only.</p>
       </div>
       <div class="logo"><a class="img" href="http://www.sebelapharma.com/" target="_blank"></a></div>
     </div>
   </div>
 </div>
</div>
</body>
<script>
 (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
   (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
   m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
 })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
 
 ga('create', 'UA-89239852-1', 'auto');
 ga('send', 'pageview');
 
</script>
</html>